Compare TMC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMC | BHVN |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2020 | 2022 |
| Metric | TMC | BHVN |
|---|---|---|
| Price | $2.28 | $13.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 17 |
| Target Price | $10.90 | ★ $23.73 |
| AVG Volume (30 Days) | ★ 4.5M | 3.0M |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.00 | 26.08 |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.91 | $7.99 |
| 52 Week High | $10.05 | $18.24 |
| Indicator | TMC | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 47.39 |
| Support Level | $1.91 | $13.56 |
| Resistance Level | $2.97 | $15.27 |
| Average True Range (ATR) | 0.25 | 1.00 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 33.97 | 12.82 |
TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.